.INVESTIGATION EMPHASIZE.16 Oct 2024.
In the NIAGARA hearing, the addition of perioperative durvalumab to basic therapy for muscle-invasive bladder cancer strengthened event-free and also in general survival, noting a brand-new therapy option for this health condition.